Relay Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	1,962	1,466	690	1,357	1,806	3,318
Market Cap Growth	192.37%	112.63%	-49.19%	-24.86%	-45.56%	-11.11%
Enterprise Value	1,414	903	-100	601	813	2,725
Last Close Price	9.16	8.46	4.12	11.01	14.94	30.71
PS Ratio	126.06	95.49	68.91	53.13	1307.87	1095.42
PB Ratio	2.81	2.59	0.89	1.81	1.90	3.70
P/TBV Ratio	3.41	2.59	0.89	1.81	1.91	3.71
EV/Sales Ratio	92.06	58.82	-	23.53	588.46	899.58
Debt / Equity Ratio	0.06	0.06	0.06	0.07	0.06	0.03
Net Debt / Equity Ratio	-0.92	-0.92	-0.94	-0.93	-0.99	-1.04
Net Debt / EBITDA Ratio	1.75	1.75	1.93	1.86	3.07	4.21
Net Debt / FCF Ratio	2.21	2.21	2.92	2.29	3.95	12.01
Asset Turnover	0.02	0.02	0.01	0.03	0.00	0.00
Quick Ratio	21.68	21.68	15.40	24.78	15.76	39.60
Current Ratio	22.61	22.61	15.95	25.44	16.00	40.14
Return on Equity (ROE)	-41.12%	-41.12%	-44.15%	-40.18%	-31.44%	-43.81%
Return on Assets (ROA)	-25.35%	-25.35%	-28.11%	-24.40%	-18.44%	-15.63%
Return on Capital Employed (ROCE)	-50.80%	-50.80%	-47.00%	-46.60%	-30.00%	-23.00%
Earnings Yield	-14.28%	-18.86%	-48.97%	-25.20%	-16.08%	-10.97%
FCF Yield	-12.19%	-16.09%	-36.41%	-22.43%	-13.21%	-2.35%
Buyback Yield / Dilution	-20.10%	-20.10%	-16.55%	-9.21%	-17.97%	-123.22%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q